TD Securities Raises Price Target on SXC Health Solutions (SXCI); Getting VIP Card to PBM Industry

Article Stock Quotes (1) Comments (0)

TD Securities maintains a 'Buy' on SXC Health Solutions (NASDAQ: SXCI) price target of $116.00 (from $106.00).

Analyst, Lennox Gibbs, said, "We are increasing our Target Price to reflect accretion
from the recently closed Catalyst acquisition. SXC now belongs to an exclusive group of high-growth, large-cap healthcare companies. More importantly, the Catalyst acquisition moved SXC into the sweet-spot of the PBM industry. In our view, the company is now large enough to take share up-market from the Big-2 PBMs, but flexible enough to continue to dominate the PBM mid-markets."

With the acquisition, TD boosts FY12 revenue estimates from $7.04B to $10.255B and FY13 from $8.783B to $15.459B.

For an analyst ratings summary and ratings history on SXC Health Solutions click here. For more ratings news on SXC Health Solutions click here.

Shares of SXC Health Solutions closed at $96.37 yesterday, with a 52 week range of $40.36-$104.79.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
• Wells Fargo Downgrades Aruba Networks (ARUN) to Market Perform
• UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?